Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Will there be a 13G filing in February?

But it also says:

"Number of Shares Beneficially Owned by Each Reporting Person With Shared Dispositive Power: 38,092,451"

Hm...

Share
New Message
Please login to post a reply